A Subgroup Analysis of Low Disease Activity and Remission from Phase 3 Study of Filgotinib in Patients with Inadequate Response to Biologic DMARDs Gottenberg, J., Buch, M., Caporali, R., Wright, G., Takeuchi, T., Kalunian, K., Pechonkina, A., Guo, Y., Rao, S., Tan, Y., Besuyen, R., Genovese, M. WILEY. 2020

View details for Web of Science ID 000587568500217